Elicio Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Elicio Therapeutics generated cash of -$32,694,000, which is less than the previous year. Cash used in financing activities reached the amount of $38,613,000 last year. Net change in cash is therefore $5,887,000.
Cash Flow
| 2019 | -9.29M | -489.1K | 6.29M |
|---|---|---|---|
| 2020 | -16.70M | -199.91K | 25.06M |
| 2021 | -23.93M | -525.35K | 19.39M |
| 2022 | -22.17M | -653.83K | 21.20M |
| 2023 | -32.69M | -32K | 38.61M |
ELTX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 8.41M | 10.04M | 15.11M | 6.81M | 10.29M |
Operating activities | |||||
Net income | -35.19M | -28.20M | -26.40M | -15.71M | -12.26M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.17M | 390.31K | 251.45K | 193.43K | 108.36K |
Stock-based compensation expense | 1.17M | 579K | 617.75K | 304.46K | 145.08K |
| Deferred income tax benefit | 1.17M | 579K | 617.75K | 304.46K | 145.08K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | -333K |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 23K | 1.12M | 30.22K | 1.12M | -962 |
Cash generated by operating activities | -32.69M | -22.17M | -23.93M | -16.70M | -9.29M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -66K | -653.83K | -525.35K | -199.91K | -489.1K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -32K | -653.83K | -525.35K | -199.91K | -489.1K |
Financing activities | |||||
Common Stock Issued | 6.99M | 21.20M | 101.38K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -150K | 0 | 0 | 0 | -375K |
Repayments of term debt | 10M | 0 | -437.99K | 0 | 0 |
Cash used in financing activities | 38.61M | 21.20M | 19.39M | 25.06M | 6.29M |
Net Change In Cash | 5.88M | -1.63M | -5.07M | 8.15M | -3.48M |
Cash at end of period | 14.30M | 8.41M | 10.04M | 14.96M | 6.81M |